Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detectedMarc Suárez‐Calvet, Natàlia Vilor‐Tejedor, Karine Fauria et al.|EMBO Molecular Medicine|2020Cited by 411
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's <i>continuum</i>Marta Milà‐Alomà, Gemma Salvadó, Juan Domingo Gispert et al.|Alzheimer s & Dementia|2020Cited by 260
Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept studyNikolaos Perakakis, Christos S. Mantzoros, Stergios A. Pοlyzos et al.|Metabolism|2019Cited by 135
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuumNatàlia Vilor‐Tejedor, Marc Vilanova, Iacopo Ciampa et al.|Alzheimer s Research & Therapy|2021Cited by 68